Mark D. Miller

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial”.

Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial

The Lancet Respiratory Medicine(2023)10.1016/s2213-2600(23)00147-9

N/A

0.869DataRank · unranked

19 citations

Christina E. Barkauskas, Birgit Grund, Shweta Sharma, Andrew Phillips, Lindsay Leither +95 more

Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad446

N/A

0.241DataRank · unranked

4 citations

Greg Grandits, Mamta K. Jain, Thomas A. Murray, Birgit Grund, Kathryn Shaw‐Saliba +93 more

Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19

Clinical Infectious Diseases(2024)10.1093/cid/ciad780

N/A

0DataRank · unranked

16 citations

Jacquie Nordwall, Dominique L. Braun, Lucy Chung, Jordan Coslet, Tatyana Der +93 more